Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Harumi Kato, MD, Naoyuki Tange, MD, Chisako Iriyama, MD PhD, Yuki Kojima, MD, Hirofumi Taji, MD PhD, Tomohiro Kinoshita, MD PhD, Yasushi Yatabe, MD PhD, Shigeo Nakamura, MD PhD, Kazuhito Yamamoto, MDPhD

Blood (2017) 130 (Supplement 1): 4063.

https://doi.org/10.1182/blood.V130.Suppl_1.4063.4063

Published: 2017

Journal Articles

Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP Regimen

Satsuki Murakami, Harumi Kato, MD, Kazuhito Yamamoto, MD, PhD, Hirofumi Taji, MD, PhD, Yusuke Higuchi, Yasushi Yatabe, MD, PhD, Shigeo Nakamura, MD, Tmohiro Kinoshita, MD

Blood (2014) 124 (21): 2972.

https://doi.org/10.1182/blood.V124.21.2972.2972

Published: 2014

Journal Articles

Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP Chemotherapy

Satsuki Murakami, M.D., Harumi Kato, M.D, Ph.D., Kazuhito Yamamoto, M.D., Ph.D., Hirofumi Taji, M.D., Ph.D., Daiki Hirano, M.D., Yasushi Yatabe, M.D., Ph.D., Shigeo Nakamura, M.D., Ph.D., Tomohiro Kinoshita, MD, PhD

Blood (2013) 122 (21): 4368.

https://doi.org/10.1182/blood.V122.21.4368.4368

Published: 2013

Journal Articles

Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy

Harumi Kato, M.D., Ph.D., Takeshi Kodaira, M.D., Ph.D., Kazuhito Yamamoto, M.D., Ph.D., Yukihiko Oshima, M.D., Ph.D., Yasuhiro Oki, M.D., Hiroyuki Tachibana, M.D., Hirofumi Taji, M.D., Ph.D., Satsuki Murakami, M.D., Daiki Hirano, M.D., Natsuo Tomita, M.D., Ph.D., Yasushi Yatabe, M.D., Ph.D., Shigeo Nakamura, M.D., Ph.D., Tomohiro Kinoshita, M.D., Ph.D.

Blood (2012) 120 (21): 3665.

https://doi.org/10.1182/blood.V120.21.3665.3665

Published: 2012

Journal Articles

Incidence and Risk Factors for Central Nervous System (CNS) Relapse In Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis with Competing Risk Regression (CRR) Model

Dai Chihara, MD, Yasuhiro Oki, MD, Keitaro Matsuo, MD, PhD, Hiroshi Onoda, MD, Hirofumi Taji, MD, PhD, Kazuhito Yamamoto, MD, PhD, Yasuo Morishima, MD, PhD

Blood (2010) 116 (21): 4154.

https://doi.org/10.1182/blood.V116.21.4154.4154

Published: 2010

Journal Articles

Gastric Diffuse Large B-Cell Lymphoma: Analyses of Prognostic Factors and Value of Pretreatment FDG-PET Scan.

Dai Chihara, MD, Yasuhiro Oki, MD, Shouji Ine, MD, PhD, Hiroshi Onoda, MD, Harumi Kato, MD, Hirofumi Taji, MD, PhD, Yoshitoyo Kagami, MD, PhD, Kazuhito Yamamoto, MD, PhD, Yasuo Morishima, MD, PhD

Blood (2009) 114 (22): 3703.

https://doi.org/10.1182/blood.V114.22.3703.3703

Published: 2009

Journal Articles

Patterns of Relapse and Value of Follow up Procedures in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Who Achieve a Complete Remission (CR)

Yasuhiro Oki, Dai Chihara, Yoshitoyo Kagami, Shouji Ine, Harumi Kato, Hirofumi Taji, Kazuhito Yamamoto, Yasuo Morishima

Blood (2008) 112 (11): 5306.

https://doi.org/10.1182/blood.V112.11.5306.5306

Published: 2008

Journal Articles

Curable Potential with TBI Containing Regimen (L-PAM/TBI) Followed by In Vivo Purged Auto-PBSCT for Patients with Relapsed or Refractory Follicular Lymphoma.

Akane Tsujimura, Hirofumi Taji, Harumi Kato, Yoshitoyo Kagami, Kazuhito Yamamoto, Michinori Ogura, Yasuo Morishima

Blood (2006) 108 (11): 5440.

https://doi.org/10.1182/blood.V108.11.5440.5440

Published: 2006

Journal Articles

Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

Keitaro Matsuo, Ritsuro Suzuki, Nobuyuki Hamajima, Michinori Ogura, Yoshitoyo Kagami, Hirofumi Taji, Eisei Kondoh, Satoko Maeda, Shoji Asakura, Sadayuki Kaba, Shigeo Nakamura, Masao Seto, Yasuo Morishima, Kazuo Tajima

Blood (2001) 97 (10): 3205–3209.

https://doi.org/10.1182/blood.V97.10.3205

Published: 2001

NARROW

Evaluation of Tumor Burden for Predicting Survival in Patients with Follicular Lymphoma Receiving First-Line R-CHOP Treatment: Comparison of Different Definition of GELF Criteria

Combination of High Serum Lactate Dehydrogenase Levels at the Time of First Diagnosis and Progression Predicts Early Lymphoma Related Death in Patients with Follicular Lymphoma Receiving R-CHOP Regimen

Prognostic Value Of GELF Criteria and FLIPI2 For Newly Diagnosed Follicular Lymphoma Receiving R-CHOP Chemotherapy

Durable Local Disease Control and Survival in Patients with Limited-Stage Diffuse Large B-Cell Lymphoma Receiving Involved-Node Radiation Therapy Plus Short-Course R-CHOP or CHOP Chemotherapy: Involved-Node Versus Involved-Field Radiation Therapy

Incidence and Risk Factors for Central Nervous System (CNS) Relapse In Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Analysis with Competing Risk Regression (CRR) Model

Gastric Diffuse Large B-Cell Lymphoma: Analyses of Prognostic Factors and Value of Pretreatment FDG-PET Scan.

Patterns of Relapse and Value of Follow up Procedures in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Who Achieve a Complete Remission (CR)

Curable Potential with TBI Containing Regimen (L-PAM/TBI) Followed by In Vivo Purged Auto-PBSCT for Patients with Relapsed or Refractory Follicular Lymphoma.

Association between polymorphisms of folate- and methionine-metabolizing enzymes and susceptibility to malignant lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only